Abstract:In recent years, the most common pharmacological treatment for Alzheimer's disease (AD) has been acetylcholinesterase (AChE) inhibition. However, this single-target approach has limited effectiveness and there is evidence that a multitarget approach might be more effective. Huperzine A (HupA), a novel alkaloid isolated from a Chinese herb, has neuroprotective effects that go beyond the inhibition of AChE. Recent data have demonstrated that HupA can ameliorate the learning and memory deficiency in animal models and AD patients. Its potentially beneficial actions include modification of β-amyloid peptide processing, reduction of oxidative stress, neuronal protection against apoptosis, and regulation of the expression and secretion of nerve growth factor (NGF) and NGF signaling. In recent years, the most common pharmacological treatment for Alzheimer's disease (AD) has been acetylcholinesterase (AChE) inhibition. However, this single-target approach has limited effectiveness and there is evidence that a multitarget approach might be more effective. Huperzine A (HupA), a novel alkaloid isolated from a Chinese herb, has neuroprotective effects that go beyond the inhibition of AChE. Recent data have demonstrated that HupA can ameliorate the learning and memory deficiency in animal models and AD patients. Its potentially beneficial actions include modification of β-amyloid peptide processing, reduction of oxidative stress, neuronal protection against apoptosis, and regulation of the expression and secretion of nerve growth factor (NGF) and NGF signaling. an enzyme found in most plant and animal cells that functions as an oxidative catalyst. It decomposes hydrogen peroxide into hydrogen and water. a series of enzymatic reactions in aerobic organisms involving oxidative metabolism of acetyl units and producing high-energy phosphate compounds, which serve as the main source of cellular energy. optically rotating to the right. The rotation of interest in chemistry is induced by a chiral molecule. The direction of rotation cannot be predicted from the R or S designation of the configuration at the stereocenter: in some cases the R isomer is dextrorotatory and the S isomer is levorotatory, whereas in other cases it is the other way around. an enzyme in the body that is a powerful scavenger of free radicals; it helps to prevent peroxidation of cell membranes by consuming free peroxide in the cell. optically rotating to the left. The levorotatory isomer of optically active compounds is the form usually found in nature. a by-product of lipid metabolism in the body. It is also found in many foods and can be present in high amounts in rancid food. an enzyme that catalyzes the decomposition of a superoxide into hydrogen peroxide and oxygen. a transgenic mouse strain that overexpresses a mutant form of human amyloid precursor protein with the Swedish mutation (APPSw), resulting in high Aβ levels in the brain. a dementia that is caused by disease of the blood vessels of the brain (cerebrovascular disease). It is the second most common form of dementia after AD.

Bis(12)-Hupyridone, A Novel Multifunctional Dimer, Promotes Neuronal Differentiation More Potently Than Its Monomeric Natural Analog Huperzine A Possibly Through Alpha7 Nachr

Bis(12)-Hupyridone, A Novel Acetylcholinesterase Inhibitor, Protects Against Glutamate-Induced Neuronal Excitotoxicity Via Activating Alpha 7 Nicotinic Acetylcholine Receptor/Phosphoinositide 3-Kinase/Akt Cascade

Neuroprotection against excitotoxic and ischemic insults by bis(12)-hupyridone, a novel anti-acetylcholinesterase dimer, possibly via acting on multiple targets

Inhibiting Β-Amyloid-associated Alzheimer’s Pathogenesis in Vitro and in Vivo by a Multifunctional Dimeric Bis(12)-hupyridone Derived from Its Natural Analogue

Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

Promising tacrine/huperzine A-based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors

Robust Neuritogenesis-Promoting Activity by Bis(heptyl)-Cognitin Through the Activation of alpha7-Nicotinic Acetylcholine Receptor/ERK Pathway.

Substantial Neuroprotective and Neurite Outgrowth-Promoting Activities by Bis(propyl)-cognitin Via the Activation of Alpha7-nAChR, a Promising Anti-Alzheimer’s Dimer

Preventing H₂O₂-induced apoptosis in cerebellar granule neurons by regulating the VEGFR-2/Akt signaling pathway using a novel dimeric antiacetylcholinesterase bis(12)-hupyridone.

Design, Synthesis, and Biological Evaluation of Scutellarein Carbamate Derivatives As Potential Multifunctional Agents for the Treatment of Alzheimer's Disease

The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine.

Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A

Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells

Huperzine A Promotes Hippocampal Neurogenesis in Vitro and in Vivo

A Natural Diarylheptanoid Promotes Neuronal Differentiation Via Activating ERK and PI3K-Akt Dependent Pathways

Methyl 3,4-dihydroxybenzoate promote rat cortical neurons survival and neurite outgrowth through the adenosine A2a receptor/PI3K/Akt signaling pathway.

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine

Novel Hybrid Acetylcholinesterase Inhibitors Induce Differentiation and Neuritogenesis in Neuronal Cells in vitro Through Activation of the AKT Pathway

Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A Against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons

Neuroprotective Effects of Huperzine A: New Therapeutic Targets for Neurodegenerative Disease